INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $359,000 | -73.4% | 316,146 | -47.3% | 0.00% | -50.0% |
| Q4 2021 | $1,349,000 | +2308.9% | 600,239 | +3597.0% | 0.00% | – |
| Q3 2021 | $56,000 | -87.2% | 16,236 | -88.9% | 0.00% | -100.0% |
| Q2 2021 | $438,000 | -80.4% | 146,742 | -78.8% | 0.00% | -80.0% |
| Q1 2021 | $2,236,000 | +3094.3% | 691,892 | +1759.3% | 0.01% | – |
| Q1 2019 | $70,000 | +40.0% | 37,212 | -12.8% | 0.00% | -100.0% |
| Q4 2018 | $50,000 | -80.8% | 42,671 | -14.0% | 0.00% | -66.7% |
| Q1 2016 | $261,000 | +0.8% | 49,589 | +223.4% | 0.00% | 0.0% |
| Q4 2014 | $259,000 | -0.8% | 15,336 | -21.2% | 0.00% | -25.0% |
| Q3 2014 | $261,000 | – | 19,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |